• demant_people_rene_schneider_cfo_sren_nielsen_ceo_210512_demant6236_thumb

    Interim Report 2021: Demant upgrades guidance

    On Thursday 12 August, Demant published its Interim Report for the first half-year of 2021. The Group delivered excellent performance with very strong growth and profitability in the segment Hearing Healthcare. Find the announcement and report here. To attend webcast at 2 pm please find information on “upcoming events” here.
  • om_ci_fda-approved_neuro-ci-system_wide-ppt_screen-format

    Neuro CI System gets FDA Premarket Approval

    Oticon Medical part of Demant’s Hearing Implants division announces FDA Premarket Approval for Neuro Cochlear Implant System. It is the first new cochlear implant technology to earn FDA premarket approval in more than 20 years and is expected to be made available to US hospitals and clinics in 2021. Read more
  • this-is-demant

    The stories behind the numbers

    Visit our Annual Report online universe and experience in video, pictures and texts the many cases and stories from 2020. Learn how the Demant Group creates life-changing differences through hearing health around the world.

As a shareholder, you can access a wide range of investor information via the portal. View your shareholdings, register your email address to receive electronic investor information, etc. Feel welcome to visit our Shareholder Portal.


  • Revenue
  • -3%
  • 2020: DKK 14,469 million
  • 2019: DKK 14,946 million
  • Operating profit (EBIT)
  • -29%
  • 2020: DKK 1,530 million
  • 2019: DKK 2,151 million (negative impact of IT incident of DKK 550 million)

Demant is the only company in the world that covers all areas of hearing healthcare, from hearing devices and hearing implants to diagnostic equipment and professional hearing care, and we harvest significant synergies from this unique position and expect to create new opportunities in the years to come.



Demant is an impact business whose core purpose is to help people with hearing loss. Our reason to exist is fundamentally to create life-changing differences through hearing health to millions of people around the world. That is our core contribution to society. Alongside this, we work to continuously strengthen sustainability in our operational practices.